Kelly Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
1,529
0.05% 124
2026
Q1
$233K Buy
1,529
+30
+2% +$4.6K 0.06% 116
2025
Q4
$207K Buy
+1,499
New +$196K 0.05% 121
2024
Q3
Sell
-1,455
Closed -$155K 536
2024
Q2
$155K Buy
1,455
+47
+3% +$4.72K 0.06% 121
2024
Q1
$136K Hold
1,408
0.05% 125
2023
Q4
$142K Hold
1,408
0.06% 116
2023
Q3
$143K Hold
1,408
0.07% 100
2023
Q2
$142K Hold
1,408
0.07% 99
2023
Q1
$130K Buy
1,408
+37
+3% +$3.23K 0.07% 102
2022
Q4
$124K Hold
1,371
0.07% 110
2022
Q3
$104K Sell
1,371
-25
-2% -$2.07K 0.06% 109
2022
Q2
$118K Hold
1,396
0.06% 106
2022
Q1
$123K Buy
1,396
+33
+2% +$2.86K 0.06% 113
2021
Q4
$119K Sell
1,363
-22
-2% -$1.83K 0.05% 115
2021
Q3
$113K Sell
1,385
-124,949
-99% -$11.2M 0.06% 99
2021
Q2
$1.39M Buy
126,334
+124,949
+9,022% +$11.1M 0.05% 95
2021
Q1
$118K Buy
1,385
+1,338
+2,847% +$120K 0.07% 75
2020
Q4
$4.44K Hold
47
﹤0.01% 375
2020
Q3
$4.09K Hold
47
﹤0.01% 356
2020
Q2
$4.11K Hold
47
﹤0.01% 361
2020
Q1
$3.88K Hold
47
﹤0.01% 326
2019
Q4
$4.45K Hold
47
﹤0.01% 315
2019
Q3
$4.08K Buy
+47
New +$4.22K ﹤0.01% 312

Other funds holding NVS

Kelly Financial Services's NVS Position: Q2 2026 in Review

Kelly Financial Services held its Novartis (NVS) position steady in Q2 2026 at 1,529 shares worth $240K. The position accounts for 0.05% of the portfolio, ranked #124.

Kelly Financial Services first reported a position in NVS in Q3 2019 and has held it in 23 quarters since. The position peaked at $1.39M in Q2 2021. 630 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Kelly Financial Services held 1,529 shares of Novartis worth $240K as of Q2 2026.
  • Kelly Financial Services left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.05% of Kelly Financial Services's portfolio in Q2 2026, its #124 holding.
  • Kelly Financial Services first reported a position in Novartis in Q3 2019 and has held it in 23 quarters since.
  • Kelly Financial Services's Novartis position peaked at $1.39M in Q2 2021.
  • 630 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Kelly Financial Services's 13F filing for Q2 2026, filed 14 Jul 2026.